Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: Correlation with grade of malignancy

International Journal of Experimental Pathology

Volumn 91, Issue 2, 2010, Pages 107-113

  Demasi, Ana P D ^a   Costa, Ana F ^b   Altemani, Albina ^b   Furuse, Cristiane ^a   Araújo, Ney S ^c   Araújo, Vera C ^a  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glucose transporter protein 1; Hypoxia; Mucoepidermoid carcinoma; Peroxiredoxins; Salivary gland; Tumour metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIGEN; GLUCOSE TRANSPORTER 1; HYDROGEN PEROXIDE; MITOCHONDRION ANTIGEN; PEROXIREDOXIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REOXYGENATION; SALIVARY GLAND ADENOSQUAMOUS CARCINOMA; SALIVARY GLAND CARCINOMA; UPREGULATION;

ADOLESCENT; ADULT; AGED; AUTOANTIGENS; CARCINOMA, MUCOEPIDERMOID; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOCHONDRIA; PEROXIREDOXINS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77749283836     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00702.x     Document Type: Article

References (32)

1. Airley R.E., Mobasheri A. (2007) Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53, 233 256.
2. Bell D., Luna M.A., Weber R.S., Kaye F.J., El-Naggar A.K. (2008) CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association. Genes Chromosomes Cancer 47, 309 314.
3. Brandwein M.S., Ivanov K., Wallace D.I. et al. (2001) Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am. J. Surg. Pathol. 25, 835 845.
4. Busk M., Horsman M.R., Kristjansen P.E., van der Kogel A.J., Bussink J., Overgaard J. (2008) Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int. J. Cancer 122, 2726 2734.
5. Chen W.C., McBride W.H., Iwamoto K.S. et al. (2002) Induction of radioprotective peroxiredoxin-I by ionizing irradiation. J. Neurosci. Res. 70, 794 798.
6. Costa A.F., Demasi A.P., Bonfitto V.L. et al. (2008) Angiogenesis in salivary carcinomas with and without myoepithelial differentiation. Virchows Arch. 453, 359 367.
7. Demasi A.P., Pereira G.A., Netto L.E. (2001) Cytosolic thioredoxin peroxidase I is essential for the antioxidant defense of yeast with dysfunctional mitochondria. FEBS Lett. 509, 430 434.
8. Denko N.C. (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705 713.
9. Dewhirst M.W., Cao Y., Moeller B. (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8, 425 437.
10. Fourquet S., Huang M.E., D'Autreaux B., Toledano M.B. (2008) The dual functions of thiol-based peroxidases in H2O2 scavenging and signaling. Antioxid. Redox Signal. 10, 1565 1576.
11. Gatenby R.A., Gillies R.J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891 899.
12. Gatenby R.A., Gillies R.J. (2008) A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8, 56 61.
13. Gillies R.J., Gatenby R.A. (2007) Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J. Bioenerg. Biomembr. 39, 251 257.
14. Gnepp D.R., Brandwein-Gensler M.S., El-Naggar A.K., Nagao T. (2005) Mucoepidermoid carcinoma. In : World Health Organization Classification of Tumours. Pathology & Genetics. Head and Neck Tumous, pp. 219 220 (eds L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky) 1st edn. Lyon : IARC Press.
15. Immenschuh S., Baumgart-Vogt E. (2005) Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal. 7, 768 777.
16. Kang S.W., Rhee S.G., Chang T.S., Jeong W., Choi M.H. (2005) 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11, 571 578.
17. Kim Y.J., Ahn J.Y., Liang P., Ip C., Zhang Y., Park Y.M. (2007) Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 67, 546 554.
18. Kim S.Y., Kim T.J., Lee K.Y. (2008) A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett. 582, 1913 1918.
19. Li C., Jackson R.M. (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282, C227 C241.
20. Miles K.A., Williams R.E. (2008) Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 8, 81 86.
21. Moreno-Sánchez R., Rodríguez-Enríquez S., Marín-Hernández A., Saavedra E. (2007) Energy metabolism in tumor cells. FEBS J. 274, 1393 1418.
22. Neumann C.A., Fang Q. (2007) Are peroxiredoxins tumor suppressors? Curr. Opin. Pharmacol. 7, 375 380.
23. Ortega A.D., Sánchez-Aragó M., Giner-Sánchez D., Sánchez-Cenizo L., Willers I., Cuezva J.M. (2009) Glucose avidity of carcinomas. Cancer Lett. 276, 125 135.
24. Pires F.R., de Almeida O.P., de Araújo V.C., Kowalski L.P. (2004) Prognostic factors in head and neck mucoepidermoid carcinoma. Arch. Otolaryngol. Head Neck Surg. 130, 174 180.
25. Rapidis A.D., Givalos N., Gakiopoulou H. et al. (2007) Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol. 43, 130 136.
26. Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., Woo H.A. (2005) Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17, 183 189.
27. Ristow M. (2006) Oxidative metabolism in cancer growth. Curr. Opin. Clin. Nutr. Metab. Care 9, 339 345.
28. Vargas P.A., Cheng Y., Barrett A.W., Craig G.T., Speight P.M. (2008) Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J. Oral Pathol. Med. 37, 309 318.
29. Wallace D.C. (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359 407.
30. Warburg O. (1956) On respiratory impairment in cancer cells. Science 124, 269 270.
31. Wood Z.A., Schröder E., Robin H.J., Poole L.B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32 40.
32. Zhang B., Su Y., Ai G., Wang Y., Wang T., Wang F. (2005) Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J. Radiat. Res. (Tokyo) 46, 305 312.